PRICE T ROWE ASSOCIATES INC /MD/
Position in CRL — Charles River Laboratories International, Inc.
CIK 80255
BALTIMORE, MD
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$341,402,862
+$147,315,695 QoQ
Shares Held
1,505,370
+33.8% QoQ
Ownership
3.15%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#11
of 570 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,000,860,485 across 31 Diagnostics & Research names. CRL ranks #11 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,116,336 | $2,565,126,216 | |
| 2 | NTRA |
Natera, Inc.
|
9,021,895 | $2,448,993,397 | |
| 3 | DHR |
Danaher Corp /De/
|
11,450,715 | $2,181,132,192 | |
| 4 | DGX |
Quest Diagnostics Inc
|
5,444,986 | $1,154,064,781 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
2,069,677 | $1,096,080,242 | |
| 6 | GH |
Guardant Health, Inc.
|
6,514,952 | $977,438,248 | |
| 7 | WAT |
Waters Corp /De/
|
2,177,958 | $816,821,367 | |
| 8 | RVTY |
Revvity, Inc.
|
5,530,850 | $615,362,370 |
All Filings in CRL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,402,862 | 1,505,370 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $194,087,167 | 1,125,143 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,533,314 | 72,856 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,399,049 | 72,856 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,299,333 | 74,470 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,434,703 | 75,968 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $31,607,027 | 171,219 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $34,057,294 | 172,906 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $132,414,680 | 640,985 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $358,318,910 | 1,322,454 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $341,166,569 | 1,443,175 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $329,378,294 | 1,680,673 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $524,887,863 | 2,496,494 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $505,820,053 | 2,506,293 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $403,660,403 | 1,852,503 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $312,223,003 | 1,586,499 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $236,285,359 | 1,104,292 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $62,832,054 | 221,263 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $82,654,605 | 219,371 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $91,523,603 | 221,784 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $106,117,100 | 286,865 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $71,652,642 | 247,223 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $66,675,890 | 266,853 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $64,640,831 | 285,453 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $69,335,856 | 397,682 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $76,366,768 | 605,077 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||